Alloferon's newly developed drugs and new drug candidates retain a wide-range of disease treatment capabilities that provide general control or correction of the human immune system.
Due to the nature of the immune modulating substances, extensive research is required to identify its precise active mechanisms. Our company has pursued a consistent study on the active mechanism of the immune modulating substances
with world-renowned immunologists, virus specialists, cancer specialists, and research organizations in an effort to expand
the range of application of treatment using the identified substances.
According to recent studies, Alloferon has been proven to penetrate the BBB (Blood Brain Barrier) to stimulate the CNS
(Central Nervous System) for analgesic effects.
Also, animal testing proved the visceral inflammation relieving effects of Alloferon. Our company’s research objective is to expand the application of the peptides and other new substances in areas where effective treatment does not yet exist.